Analysis of lipid nanoparticles using two-dimensional chromatography: Simultaneous determination of encapsulation efficiency, nucleic acid integrity, and size of LNP formulations
Journal of Chromatography B · 2025-11 · 1265 · 124751
DOI: 10.1016/j.jchromb.2025.124751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chromatography B, 2025-11. Verfasst von Nejc Pavlin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sartorius BIA Separations d.o.o., Mirce 21, 5270 Ajdovscina, Slovenia. Electronic address: nejc.pavlin@biaseparations.com. Hauptthemen laut MEDLINE: Lipids, Nanoparticles, Nucleic Acids. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Lipid nanoparticles (LNPs) have emerged as the most advanced drug delivery system for gene therapies and vaccines due to their ability to encapsulate a diverse range of payloads, including nucleic acids and proteins. LNPs provide many benefits, such as protection of payloads from enzymatic degradation, enhanced cellular uptake, and controlled release, making them promising candidates for therapeutic applications. The complex composition and inherent instabilities of LNPs present significant challenges for their characterization, especially in determining encapsulation efficiency, payload integrity, and size distribution. This study presents a two-dimensional chromatography (2D) method to simultaneously assess crucial parameters of LNP formulations. The method employs a switching chromatography system comprising two distinct analytical columns, independent pumps, and two detectors, including an ultraviolet-visible detector (UV-Vis) and a multi-angle light scattering detector (MALS). A key benefit of this advanced configuration is the direct analysis of LNPs without the need for sample preparation. The 2D technique enables accurate quantification of both encapsulated and non-encapsulated nucleic acids, evaluation of payload integrity, and determination of LNP size and size distribution. The results demonstrate that this method provides a comprehensive and robust analytical solution, enabling further development and understanding of lipid-based drug delivery systems. The validation of the technique confirms its sensitivity (LOD 15 ng mRNA, LOQ 45 ng mRNA), linearity (R2 > 0.99), precision (RSD < 15 %), accuracy (< 15 %), and potential to streamline and optimize process development, in-process control, and quality control of LNP formulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sartorius BIA Separations d.o.o., Mirce 21, 5270 Ajdovscina, Slovenia. Electronic address: nejc.pavlin@biaseparations.com.
- Sartorius BIA Separations d.o.o., Mirce 21, 5270 Ajdovscina, Slovenia.
Zitieren
APA
Pavlin, N., Bavčar, M., Kovačič, T., Kašček, T., Celjar, A. M., Bergoč, I., Livk, A. G., & Štrancar, A. (2025). Analysis of lipid nanoparticles using two-dimensional chromatography: Simultaneous determination of encapsulation efficiency, nucleic acid integrity, and size of LNP formulations. Journal of Chromatography B, 1265, 124751. https://doi.org/10.1016/j.jchromb.2025.124751
Vancouver
Pavlin N, Bavčar M, Kovačič T, Kašček T, Celjar AM, Bergoč I, et al. Analysis of lipid nanoparticles using two-dimensional chromatography: Simultaneous determination of encapsulation efficiency, nucleic acid integrity, and size of LNP formulations. Journal of Chromatography B. 2025;1265:124751. doi:10.1016/j.jchromb.2025.124751
BibTeX
@article{Pavlin2025,
author = {Pavlin, Nejc and Bavčar, Mojca and Kovačič, Tristan and Kašček, Tjaša and Celjar, Anže Martinčič and Bergoč, Ines and Livk, Andreja Gramc and Štrancar, Aleš},
title = {Analysis of lipid nanoparticles using two-dimensional chromatography: Simultaneous determination of encapsulation efficiency, nucleic acid integrity, and size of LNP formulations},
journal = {Journal of Chromatography B},
year = {2025},
volume = {1265},
pages = {124751},
doi = {10.1016/j.jchromb.2025.124751}
}
EUVIMED